KLRK1 and neoplasm: Interestingly, the apoptosis data revealed no significant difference between the NKG2D-Exo and IL24-NKG2D-Exo groups at 24 h in A549 cells, suggesting that NKG2D plays a dominant role in early tumor cell targeting and apoptosis induction.